title: Genome-wide analysis of myelodysplastic syndromes.
abstract: Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic neoplasms characterized by ineffective hematopoiesis and a risk for progression to acute myeloid leukemia. A number of cytogenetic changes have been described that are characteristic to MDS and of clinical relevance; the specific gene targets of these alterations were largely unknown. On the other hand, over the past decade, technologies have been dramatically improved to enable high-throughput analysis of entire MDS genomes, leading to identification of frequent copy number neutral events and a number of novel gene targets implicated in the pathogenesis of MDS. In this review, we briefly overview the recent progress in the genetics of MDS, focusing on the newly identified gene targets in MDS.
authors.affiliation: Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. sanada-tky@umin.ac.jp
authors.forename: Masashi
authors.initials: M
authors.lastname: Sanada
authors.forename: Seishi
authors.initials: S
authors.lastname: Ogawa
mesh_terms: D000818:Animals; D018450:Disease Progression; D055106:Genome-Wide Association Study; D006410:Hematopoiesis; D059014:High-Throughput Nucleotide Sequencing / Q000379:methods; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000209:etiology*; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000473:pathology